Add to ORKGObjective Two studies have reported that patients with the 4G/4G genotype of the plasminogen acti-vator inhibitor-1 (PAI-1) genetic polymorphism had higher plasma PAI-1 concentrations and higher risk of death than those with the 4G/5G or 5G/5G genotypes; one study involved 175 children with meningococcal disease, and the other included 88 adult patients with septic shock. Thus, the objective of this study was to determine whether there is an association be-tween carriage of the 4G/4G genotype, plasma PAI-1 concentrations and mortality in a large series of adult septic patients. Methods An observational, prospective, multicenter study was carried out in six Spanish Intensive Care Units including severe septic patients. We determined the PAI-...
) -675 4G/5G polymorphism and sepsis in different populations. However, the available results are co...
Introduction: Activation of inflammation and coagulation are closely related and mutually interdep...
Background. The type 1 plasminogen activator inhibitor (PAI-1) is involved in the development of fib...
Two studies have reported that patients with the 4G/4G genotype of the plasminogen activator inhibit...
Two studies have reported that patients with the 4G/4G genotype of the plasminogen activator inhibit...
Objective: Two studies have reported that patients with the 4G/4G genotype of the plasminogen activa...
BACKGROUND: Several studies have evaluated the association between plasminogen activator inhibitor-1...
Background: Pregnancy-induced hypertension (PIH) is a common cause of perinatal mortality. It is bel...
Plasminogen activator inhibitor type 1 (PAI-1) is a 50-kilodalton glycoprotein of the serine proteas...
PURPOSE: Plasminogen activator inhibitor 1 (PAI-1) is a critical enzyme that regulates coagulation a...
BACKGROUND: Plasminogen activator inhibitor-1 (PAI-1) plays an important role in the pathophysiology...
Background:Several studies have investigated the role of PAI-1 4G/5G and ACE I/D polymorphisms in th...
Background. Myocardial infarction (MI) is a leading cause of death, particularly in high-risk settin...
Introduction: Plasminogen activator inhibitor-1 (PAI-1) is the major physiological inhibitor of tiss...
Contains fulltext : 51641.pdf (publisher's version ) (Open Access)OBJECTIVES: Plas...
) -675 4G/5G polymorphism and sepsis in different populations. However, the available results are co...
Introduction: Activation of inflammation and coagulation are closely related and mutually interdep...
Background. The type 1 plasminogen activator inhibitor (PAI-1) is involved in the development of fib...
Two studies have reported that patients with the 4G/4G genotype of the plasminogen activator inhibit...
Two studies have reported that patients with the 4G/4G genotype of the plasminogen activator inhibit...
Objective: Two studies have reported that patients with the 4G/4G genotype of the plasminogen activa...
BACKGROUND: Several studies have evaluated the association between plasminogen activator inhibitor-1...
Background: Pregnancy-induced hypertension (PIH) is a common cause of perinatal mortality. It is bel...
Plasminogen activator inhibitor type 1 (PAI-1) is a 50-kilodalton glycoprotein of the serine proteas...
PURPOSE: Plasminogen activator inhibitor 1 (PAI-1) is a critical enzyme that regulates coagulation a...
BACKGROUND: Plasminogen activator inhibitor-1 (PAI-1) plays an important role in the pathophysiology...
Background:Several studies have investigated the role of PAI-1 4G/5G and ACE I/D polymorphisms in th...
Background. Myocardial infarction (MI) is a leading cause of death, particularly in high-risk settin...
Introduction: Plasminogen activator inhibitor-1 (PAI-1) is the major physiological inhibitor of tiss...
Contains fulltext : 51641.pdf (publisher's version ) (Open Access)OBJECTIVES: Plas...
) -675 4G/5G polymorphism and sepsis in different populations. However, the available results are co...
Introduction: Activation of inflammation and coagulation are closely related and mutually interdep...
Background. The type 1 plasminogen activator inhibitor (PAI-1) is involved in the development of fib...